{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:42:42Z","timestamp":1772034162492,"version":"3.50.1"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["TA 1154\/1-2, TA 1154\/2-2"],"award-info":[{"award-number":["TA 1154\/1-2, TA 1154\/2-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["HE 5208\/5-2"],"award-info":[{"award-number":["HE 5208\/5-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SA 4275\/1-1"],"award-info":[{"award-number":["SA 4275\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>The present review addresses most recently identified mechanisms implicated in metastasis-induced bone resorption and muscle-wasting syndrome, known as cachexia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Metastatic disease in bone and soft tissues is often associated with skeletal muscle defects. Recent studies have identified a number of secreted molecules and extracellular vesicles that contribute to cancer cell growth and metastasis leading to bone destruction and muscle atrophy. In addition, alterations in muscle microenvironment including dysfunctions in hepatic and mitochondrial metabolism have been implicated in cancer-induced regeneration defect and muscle loss. Moreover, we review novel in vitro and animal models including promising new drug candidates for bone metastases and cancer cachexia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Preservation of bone health could be highly beneficial for maintaining muscle mass and function. Therefore, a better understanding of molecular pathways implicated in bone and muscle crosstalk in metastatic disease may provide new insights and identify new strategies to improve current anticancer therapeutics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11914-022-00741-y","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T07:03:14Z","timestamp":1661151794000},"page":"273-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Muscle and Bone Defects in Metastatic Disease"],"prefix":"10.1007","volume":"20","author":[{"given":"Martina","family":"Pauk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-9333","authenticated-orcid":false,"given":"Hanna","family":"Taipaleenm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"741_CR1","first-page":"482","volume":"8","author":"J-F Huang","year":"2020","unstructured":"Huang J-F, Shen J, Li X, Rengan R, Silvestris N, Wang M, et al. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl med [internet]. AME Publishing Company. 2020;8:482 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32395526.","journal-title":"AME Publishing Company"},{"key":"741_CR2","first-page":"321","volume-title":"Oncol rev [internet]","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, et al. Bone metastases: an overview. In: Oncol rev [internet], vol. 11. Pavia, Italy: PAGEPress Publications; 2017. p. 321. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28584570."},{"key":"741_CR3","first-page":"388","volume-title":"Cells [internet]","author":"H Shao","year":"2022","unstructured":"Shao H, Varamini P. Breast cancer bone metastasis: a narrative review of emerging targeted drug delivery systems. In: Cells [internet], vol. 11: MDPI; 2022. p. 388. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35159207."},{"key":"741_CR4","doi-asserted-by":"crossref","unstructured":"Li X, Jin L, Tan Y. Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis (review). Mol Med Rep [Internet]. 2020\/11\/25. D.A. Spandidos; 2021;23:70. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33236155","DOI":"10.3892\/mmr.2020.11708"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol [Internet]. 2019;20:69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4.","journal-title":"Nat Rev Mol Cell Biol [Internet]"},{"key":"741_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00330-009-1577-1","volume":"20","author":"A Surov","year":"2010","unstructured":"Surov A, Hainz M, Holzhausen H-J, Arnold D, Katzer M, Schmidt J, et al. Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol [internet]. Germany. 2010;20:649\u201358. https:\/\/doi.org\/10.1007\/s00330-009-1577-1.","journal-title":"Germany"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","volume":"24","author":"G Wang","year":"2018","unstructured":"Wang G, Biswas AK, Ma W, Kandpal M, Coker C, Grandgenett PM, et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat Med [Internet]. 2018;24:770\u201381. https:\/\/doi.org\/10.1038\/s41591-018-0054-2.","journal-title":"Nat Med [Internet]"},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-020-0251-4","volume":"20","author":"AK Biswas","year":"2020","unstructured":"Biswas AK, Acharyya S. Understanding cachexia in the context of metastatic progression. Nat Rev Cancer [Internet]. 2020;20:274\u201384. https:\/\/doi.org\/10.1038\/s41568-020-0251-4.","journal-title":"Nat Rev Cancer [Internet]"},{"key":"741_CR9","doi-asserted-by":"publisher","unstructured":"Biswas AK, Acharyya S. Cancer-associated cachexia: a systemic consequence of cancer progression. Annu Rev Cancer Biol [Internet]. Annual Reviews; 2020;4:391\u2013411. Available from: https:\/\/doi.org\/10.1146\/annurev-cancerbio-030419-033642","DOI":"10.1146\/annurev-cancerbio-030419-033642"},{"key":"741_CR10","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s00520-021-06603-0","volume":"30","author":"B Raynard","year":"2022","unstructured":"Raynard B, Pigneur F, Di Palma M, Deluche E, Goldwasser F. The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study). Support Care Cancer [Internet]. 2022;30:3119\u201329. https:\/\/doi.org\/10.1007\/s00520-021-06603-0.","journal-title":"Support Care Cancer [Internet]"},{"key":"741_CR11","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/ijms21072321","volume":"21","author":"GWP da Fonseca","year":"2020","unstructured":"da Fonseca GWP, Farkas J, Dora E, von Haehling S, Lainscak M. Cancer cachexia and related metabolic dysfunction. Int J Mol Sci [Internet]. 2020;21:2321 Available from: https:\/\/www.mdpi.com\/1422-0067\/21\/7\/2321.","journal-title":"Int J Mol Sci [Internet]"},{"key":"741_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/jjco\/hyaa045","volume":"50","author":"T Ikeda","year":"2020","unstructured":"Ikeda T, Ishihara H, Iizuka J, Hashimoto Y, Yoshida K, Kakuta Y, et al. Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer. Jpn J Clin Oncol [Internet]. 2020;50:933\u20139. https:\/\/doi.org\/10.1093\/jjco\/hyaa045.","journal-title":"Jpn J Clin Oncol [Internet]"},{"key":"741_CR13","doi-asserted-by":"publisher","unstructured":"Marceca GP, Londhe P, Calore F. Management of cancer cachexia: attempting to develop new pharmacological agents for new effective therapeutic options. Front Oncol [Internet]. 2020:10. https:\/\/doi.org\/10.3389\/fonc.2020.00298\/full.","DOI":"10.3389\/fonc.2020.00298\/full"},{"key":"741_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12551-021-00789-7","volume":"13","author":"A Singh","year":"2021","unstructured":"Singh A, Phogat J, Yadav A, Dabur R. The dependency of autophagy and ubiquitin proteasome system during skeletal muscle atrophy. Biophys Rev [Internet]. 2021;13:203\u201319. https:\/\/doi.org\/10.1007\/s12551-021-00789-7.","journal-title":"Biophys Rev [Internet]"},{"key":"741_CR15","doi-asserted-by":"publisher","unstructured":"Penna F, Ballar\u00f2 R, Beltr\u00e0 M, De Lucia S, Garc\u00eda Castillo L, Costelli P. The skeletal muscle as an active player against cancer cachexia. Front Physiol [Internet]. 2019:10. https:\/\/doi.org\/10.3389\/fphys.2019.00041\/full.","DOI":"10.3389\/fphys.2019.00041\/full"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/ajcn\/nqz347","volume":"111","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang J, Wang X, Gao T, Tian H, Zhou D, et al. The autophagic-lysosomal and ubiquitin proteasome systems are simultaneously activated in the skeletal muscle of gastric cancer patients with cachexia. Am J Clin Nutr [Internet]. 2020;111:570\u20139. https:\/\/doi.org\/10.1093\/ajcn\/nqz347.","journal-title":"Am J Clin Nutr [Internet]"},{"key":"741_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","volume":"66","author":"JM Argil\u00e9s","year":"2019","unstructured":"Argil\u00e9s JM, L\u00f3pez-Soriano FJ, Busquets S. Mediators of cachexia in cancer patients. Nutrition [Internet]. 2019;66:11\u20135 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0899900719300358.","journal-title":"Nutrition [Internet]"},{"key":"741_CR18","doi-asserted-by":"publisher","first-page":"9268","DOI":"10.3390\/ijms21239268","volume":"21","author":"VS Armstrong","year":"2020","unstructured":"Armstrong VS, Fitzgerald LW, Bathe OF. Cancer-associated muscle wasting\u2014candidate mechanisms and molecular pathways. Int J Mol Sci [Internet]. 2020;21:9268 Available from: https:\/\/www.mdpi.com\/1422-0067\/21\/23\/9268.","journal-title":"Int J Mol Sci [Internet]"},{"key":"741_CR19","doi-asserted-by":"crossref","unstructured":"Rupert JE, Narasimhan A, Jengelley DHA, Jiang Y, Liu J, Au E, et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J Exp Med [Internet]. 2021:218 Available from: https:\/\/rupress.org\/jem\/article\/218\/6\/e20190450\/211985\/Tumor-derived-IL-6-and-trans-signaling-among-tumor.","DOI":"10.1084\/jem.20190450"},{"key":"741_CR20","doi-asserted-by":"publisher","unstructured":"Baazim H, Antonio-Herrera L, Bergthaler A. The interplay of immunology and cachexia in infection and cancer. Nat Rev Immunol [Internet]. 2021. https:\/\/doi.org\/10.1038\/s41577-021-00624-w.","DOI":"10.1038\/s41577-021-00624-w"},{"key":"741_CR21","doi-asserted-by":"crossref","unstructured":"Okugawa Y, Toiyama Y, Hur K, Yamamoto A, Yin C, Ide S, et al. Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients. J Cachexia Sarcopenia Muscle [Internet]. 2019;10:536\u201348. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcsm.12403","DOI":"10.1002\/jcsm.12403"},{"key":"741_CR22","doi-asserted-by":"crossref","unstructured":"Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, et al. Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice. Nat Med [Internet]. 2015;21:1262\u201371. Available from: http:\/\/www.nature.com\/articles\/nm.3961","DOI":"10.1038\/nm.3961"},{"key":"741_CR23","doi-asserted-by":"crossref","unstructured":"Inaba S, Hinohara A, Tachibana M, Tsujikawa K, Fukada S-I. Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential. Asakura A, editor. PLoS One [Internet]. 2018;13:e0205467. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0205467","DOI":"10.1371\/journal.pone.0205467"},{"key":"741_CR24","doi-asserted-by":"crossref","unstructured":"Costamagna D, Duelen R, Penna F, Neumann D, Costelli P, Sampaolesi M. Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice. J Cachexia Sarcopenia Muscle [Internet]. 2020\/02\/27. John Wiley and Sons Inc.; 2020;11:783\u2013801. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32103619","DOI":"10.1002\/jcsm.12539"},{"key":"741_CR25","doi-asserted-by":"crossref","unstructured":"Beltr\u00e0 M, Pin F, Ballar\u00f2 R, Costelli P, Penna F. Mitochondrial dysfunction in cancer cachexia: impact on muscle health and regeneration. Cells. 2021;10.","DOI":"10.3390\/cells10113150"},{"key":"741_CR26","doi-asserted-by":"crossref","unstructured":"Waning DL, Guise TA. Molecular mechanisms of bone metastasis and associated muscle weakness. Clin Cancer Res [Internet]. 2014\/03\/27. 2014;20:3071\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24677373","DOI":"10.1158\/1078-0432.CCR-13-1590"},{"key":"741_CR27","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Hesse E, Schr\u00f6der S, Brandt D, Pamperin J, Saito H, Taipaleenm\u00e4ki H. Sclerostin inhibition alleviates breast cancer\u2013induced bone metastases and muscle weakness. JCI Insight [Internet]. 2019;4. Available from: https:\/\/insight.jci.org\/articles\/view\/125543. This study shows that bone matrix\u2013derived TGF-\u00df contributes to reduced muscle function in breast cancer metastasis, which is abrogated with anti-sclerostin therapy. Authors suggest that anti-sclerostin therapy could be used as a promising pharmacological candidate for both muscle and bone defects in breast cancer patients by intervening with the vicious cycle of bone metastasis.","DOI":"10.1172\/jci.insight.125543"},{"key":"741_CR28","doi-asserted-by":"crossref","unstructured":"Regan JN, Mikesell C, Reiken S, Xu H, Marks AR, Mohammad KS, et al. Osteolytic breast cancer causes skeletal muscle weakness in an immunocompetent syngeneic mouse model. Front Endocrinol (Lausanne) [Internet]. 2017;8:358. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00358\/full","DOI":"10.3389\/fendo.2017.00358"},{"key":"741_CR29","doi-asserted-by":"publisher","first-page":"116245","DOI":"10.1016\/j.bone.2021.116245","volume":"154","author":"T Trivedi","year":"2022","unstructured":"Trivedi T, Guise TA. Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition. Bone [Internet]. 2022;154:116245 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328221004117.","journal-title":"Bone [Internet]"},{"key":"741_CR30","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1172\/JCI68523","volume":"123","author":"WA He","year":"2013","unstructured":"He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J, et al. NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013;123:4821\u201335.","journal-title":"J Clin Invest"},{"key":"741_CR31","doi-asserted-by":"crossref","unstructured":"Theret M, Rossi FM V, Contreras O. Evolving roles of muscle-resident fibro-adipogenic progenitors in health, regeneration, neuromuscular disorders, and aging [Internet]. Front. Physiol. 2021. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2021.673404","DOI":"10.3389\/fphys.2021.673404"},{"key":"741_CR32","doi-asserted-by":"crossref","unstructured":"Shakri AR, James Zhong T, Ma W, Coker C, Hegde R, Scholze H, et al. Aberrant Zip14 expression in muscle is associated with cachexia in a Bard1 -deficient mouse model of breast cancer metastasis. Cancer Med [Internet]. 2020;9:6766\u201375. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.3242","DOI":"10.1002\/cam4.3242"},{"key":"741_CR33","doi-asserted-by":"crossref","unstructured":"Shakri AR, Zhong TJ, Ma W, Coker C, Kim S, Calluori S, et al. Upregulation of ZIP14 and altered zinc homeostasis in muscles in pancreatic cancer cachexia. Cancers (Basel) [Internet]. 2019;12:3. Available from: https:\/\/www.mdpi.com\/2072-6694\/12\/1\/3","DOI":"10.3390\/cancers12010003"},{"key":"741_CR34","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Huot JR, Novinger LJ, Pin F, Narasimhan A, Zimmers TA, O\u2019Connell TM, et al. Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia. JCI Insight [Internet]. 2020;5. Available from: https:\/\/insight.jci.org\/articles\/view\/136687. In this study, authors report that advanced colorectal cancer mouse models with intrasplenically injected C26 tumor cells exhibit skeletal muscle wasting accompanied with bone loss, altered mitochondria homeostasis and increased myosteatosis. Moreover, liver metastases exarcerbate cachetic phenotype supporting the need to use metastatic in vivo models to faithfully mimic cancer cachexia in human patients.","DOI":"10.1172\/jci.insight.136687"},{"key":"741_CR35","doi-asserted-by":"crossref","unstructured":"Huot JR, Novinger LJ, Pin F, Bonetto A. HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia. Dis Model Mech [Internet]. 2020;13. Available from: https:\/\/journals.biologists.com\/dmm\/article\/doi\/10.1242\/dmm.043166\/267155\/HCT116-colorectal-liver-metastases-exacerbate","DOI":"10.1242\/dmm.043166"},{"key":"741_CR36","doi-asserted-by":"crossref","unstructured":"Huot JR, Pin F, Essex AL, Bonetto a. MC38 tumors induce musculoskeletal defects in colorectal cancer. Int J Mol Sci [Internet]. MDPI; 2021;22:1486. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33540821","DOI":"10.3390\/ijms22031486"},{"key":"741_CR37","first-page":"19863","volume":"7","author":"P Wu","year":"2016","unstructured":"Wu P, Wu D, Zhao L, Huang L, Shen G, Huang J, et al. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis. Oncotarget [internet]. Impact Journals LLC. 2016;7:19863\u201383 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26959884.","journal-title":"Impact Journals LLC"},{"key":"741_CR38","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1111\/bph.15625","volume":"178","author":"M Niu","year":"2021","unstructured":"Niu M, Song S, Su Z, Wei L, Li L, Pu W, et al. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice. Br J Pharmacol. 2021;178:4485\u2013500.","journal-title":"Br J Pharmacol"},{"key":"741_CR39","first-page":"1272","volume":"11","author":"TK Sin","year":"2019","unstructured":"Sin TK, Zhang G, Zhang Z, Gao S, Li M, Li Y-P. Cancer takes a toll on skeletal muscle by releasing heat shock proteins-an emerging mechanism of cancer-induced cachexia. cancers (Basel) [Internet]. MDPI. 2019;11:1272 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31480237.","journal-title":"MDPI"},{"key":"741_CR40","doi-asserted-by":"crossref","unstructured":"Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, et al. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology [Internet]. 2018\/10\/17. 2019;156:722-734.e6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30342032","DOI":"10.1053\/j.gastro.2018.10.026"},{"key":"741_CR41","doi-asserted-by":"crossref","unstructured":"Rosa-Caldwell ME, Brown JL, Lee DE, Wiggs MP, Perry Jr RA, Haynie WS, et al. Hepatic alterations during the development and progression of cancer cachexia. Appl Physiol Nutr Metab [Internet]. 2019\/10\/16. 2020;45:500\u2013512. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31618604","DOI":"10.1139\/apnm-2019-0407"},{"key":"741_CR42","doi-asserted-by":"crossref","unstructured":"Khamoui A V, Tokmina-Roszyk D, Rossiter HB, Fields GB, Visavadiya NP. Hepatic proteome analysis reveals altered mitochondrial metabolism and suppressed acyl-CoA synthetase-1 in colon-26 tumor-induced cachexia. Physiol Genomics [Internet]. 2020\/03\/09. Am Physiol Soc; 2020;52:203\u2013216. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32146873","DOI":"10.1152\/physiolgenomics.00124.2019"},{"key":"741_CR43","doi-asserted-by":"publisher","unstructured":"Kurosawa T, Goto M, Kaji N, Aikiyo S, Mihara T, Ikemoto-Uezumi M, et al. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNF\u03b1. Cell Death Dis [Internet]. 2021;12:11. Available from. https:\/\/doi.org\/10.1038\/s41419-020-03353-5.","DOI":"10.1038\/s41419-020-03353-5"},{"key":"741_CR44","doi-asserted-by":"crossref","unstructured":"Giusto M, Barberi L, Di Sario F, Rizzuto E, Nicoletti C, Ascenzi F, et al. Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis. Physiol Rep [Internet]. John Wiley and Sons Inc.; 2017;5:e13153. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28364027","DOI":"10.14814\/phy2.13153"},{"key":"741_CR45","doi-asserted-by":"publisher","unstructured":"Ballar\u00f2 R, Beltr\u00e0 M, De Lucia S, Pin F, Ranjbar K, Hulmi JJ, et al. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations. FASEB J [Internet]. John Wiley & Sons, ltd; 2019;33:5482\u20135494. Available from. https:\/\/doi.org\/10.1096\/fj.201801862R.","DOI":"10.1096\/fj.201801862R"},{"key":"741_CR46","doi-asserted-by":"crossref","unstructured":"Chu MP, Li Y, Ghosh S, Sass S, Smylie M, Walker J, et al. Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma. J Cachexia Sarcopenia Muscle [Internet]. 2020\/02\/13. John Wiley and Sons Inc.; 2020;11:748\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32053287","DOI":"10.1002\/jcsm.12538"},{"key":"741_CR47","doi-asserted-by":"crossref","unstructured":"White JP, Puppa MJ, Sato S, Gao S, Price RL, Baynes JW, et al. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse. Skelet Muscle [Internet]. BioMed Central; 2012;2:14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22769563","DOI":"10.1186\/2044-5040-2-14"},{"key":"741_CR48","first-page":"2576","volume":"10","author":"G Favaro","year":"2019","unstructured":"Favaro G, Romanello V, Varanita T, Andrea Desbats M, Morbidoni V, Tezze C, et al. DRP1-mediated mitochondrial shape controls calcium homeostasis and muscle mass. Nat Commun [Internet]. Nature Publishing Group UK. 2019;10:2576 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31189900.","journal-title":"Nature Publishing Group UK"},{"key":"741_CR49","doi-asserted-by":"crossref","unstructured":"Oost LJ, Kustermann M, Armani A, Blaauw B, Romanello V. Fibroblast growth factor 21 controls mitophagy and muscle mass. J Cachexia Sarcopenia Muscle [Internet]. 2019\/03\/20. John Wiley and Sons Inc.; 2019;10:630\u201342. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30895728","DOI":"10.1002\/jcsm.12409"},{"key":"741_CR50","doi-asserted-by":"publisher","unstructured":"Wyart E, Hsu MY, Sartori R, Mina E, Rausch V, Pierobon ES, et al. Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia. EMBO Rep [Internet]. John Wiley & Sons, Ltd; 2022;23:e53746. Available from: https:\/\/doi.org\/10.15252\/embr.202153746","DOI":"10.15252\/embr.202153746"},{"key":"741_CR51","doi-asserted-by":"crossref","unstructured":"Callaway CS, Delitto AE, Patel R, Nosacka RL, D\u2019Lugos AC, Delitto D, et al. IL-8 released from human pancreatic cancer and tumor-associated stromal cells signals through a CXCR2-ERK1\/2 axis to induce muscle atrophy. Cancers (Basel) [Internet]. MDPI; 2019;11:1863. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31769424","DOI":"10.3390\/cancers11121863"},{"key":"741_CR52","doi-asserted-by":"crossref","unstructured":"Li Z, Zhu L, Zheng H, Jiang W, Wang Y, Jiang Z, et al. Serum IL-35 levels is a new candidate biomarker of cancer-related cachexia in stage IV non-small cell lung cancer. Thorac cancer [Internet]. 2022\/02\/09. John Wiley & Sons Australia, Ltd; 2022;13:716\u201323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35142058","DOI":"10.1111\/1759-7714.14307"},{"key":"741_CR53","first-page":"1125","volume":"12","author":"DS Ahmed","year":"2021","unstructured":"Ahmed DS, Isnard S, Lin J, Routy B, Routy J-P. GDF15\/GFRAL pathway as a metabolic signature for cachexia in patients with cancer. J cancer [internet]. Ivyspring Int Publisher. 2021;12:1125\u201332 Available from:https:\/\/pubmed.ncbi.nlm.nih.gov\/33442410.","journal-title":"Ivyspring Int Publisher"},{"key":"741_CR54","doi-asserted-by":"publisher","unstructured":"Zhang W, Sun W, Gu X, Miao C, Feng L, Shen Q, et al. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2\/caspase-3 pathway. Cell Death Discov [Internet]. 2022;8:162. Available from. https:\/\/doi.org\/10.1038\/s41420-022-00972-z.","DOI":"10.1038\/s41420-022-00972-z"},{"key":"741_CR55","doi-asserted-by":"crossref","unstructured":"Yoo W, Choi H, Son YH, Lee J, Jo S, Jung D, et al. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor. Exp Mol Med [Internet]. 2021\/03\/17. Nature Publishing Group UK; 2021;53:432\u2013445. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33731895","DOI":"10.1038\/s12276-021-00582-2"},{"key":"741_CR56","doi-asserted-by":"crossref","unstructured":"Lai K-C, Hong Z-X, Hsieh J-G, Lee H-J, Yang M-H, Hsieh C-H, et al. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice. J Cachexia Sarcopenia Muscle [Internet]. 2022\/02\/15. John Wiley and Sons Inc.; 2022;13:1314\u201328. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35170238","DOI":"10.1002\/jcsm.12943"},{"key":"741_CR57","doi-asserted-by":"publisher","unstructured":"Hain BA, Xu H, Waning DL. Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice. J Cachexia Sarcopenia Muscle [Internet]. Springer nature; 2021;12:1597\u2013612. Available from. https:\/\/doi.org\/10.1002\/jcsm.12795.","DOI":"10.1002\/jcsm.12795"},{"key":"741_CR58","doi-asserted-by":"crossref","unstructured":"Dasgupta A, Arneson-Wissink PC, Schmitt RE, Cho DS, Ducharme AM, Hogenson TL, et al. Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer. JCI insight [Internet]. Am Soc Clin Invest; 2022;7:e153842. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34874916","DOI":"10.1172\/jci.insight.153842"},{"key":"741_CR59","doi-asserted-by":"crossref","unstructured":"Chen R, Lei S, Jiang T, She Y, Shi H. Regulation of skeletal muscle atrophy in cachexia by MicroRNAs and long non-coding RNAs. Front cell Dev Biol [Internet]. Frontiers Media S.A.; 2020;8:577010. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33043011","DOI":"10.3389\/fcell.2020.577010"},{"key":"741_CR60","doi-asserted-by":"publisher","unstructured":"Xie K, Xiong H, Xiao W, Xiong Z, Hu W, Ye J, et al. Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia. Cancer Cell Int [Internet]. 2021;21:627. Available from. https:\/\/doi.org\/10.1186\/s12935-021-02332-w.","DOI":"10.1186\/s12935-021-02332-w"},{"key":"741_CR61","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbrc.2020.09.066","volume":"533","author":"L Qiu","year":"2020","unstructured":"Qiu L, Chen W, Wu C, Yuan Y, Li Y. Exosomes of oral squamous cell carcinoma cells containing miR-181a-3p induce muscle cell atrophy and apoptosis by transmissible endoplasmic reticulum stress signaling. Biochem Biophys Res Commun [Internet]. 2020;533:831\u20137 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006291X20318118.","journal-title":"Biochem Biophys Res Commun [Internet]"},{"key":"741_CR62","doi-asserted-by":"crossref","unstructured":"Miao C, Zhang W, Feng L, Gu X, Shen Q, Lu S, et al. Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia. Mol Ther - Nucleic Acids [Internet]. 2021;24:923\u201338. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2162253121001098","DOI":"10.1016\/j.omtn.2021.04.015"},{"key":"741_CR63","doi-asserted-by":"crossref","unstructured":"Freire PP, Cury SS, Lopes LO, Fernandez GJ, Liu J, de Moraes LN, et al. Decreased miR-497-5p suppresses IL-6 induced atrophy in muscle cells. Cells [Internet]. MDPI; 2021;10:3527. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34944037","DOI":"10.3390\/cells10123527"},{"key":"741_CR64","doi-asserted-by":"crossref","unstructured":"van de Worp WRPH, Schols AMWJ, Dingemans A-MC, Op den Kamp CMH, Degens JHRJ, Kelders MCJM, et al. Identification of microRNAs in skeletal muscle associated with lung cancer cachexia. J Cachexia Sarcopenia Muscle [Internet]. 2019\/12\/11. John Wiley and Sons Inc.; 2020;11:452\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31828982","DOI":"10.1002\/jcsm.12512"},{"key":"741_CR65","doi-asserted-by":"crossref","unstructured":"Lee AQ, Li Y, Gong Z. Inducible liver cancer models in transgenic zebrafish to investigate cancer biology. Cancers (Basel) [Internet]. MDPI; 2021;13:5148. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34680297","DOI":"10.3390\/cancers13205148"},{"key":"741_CR66","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/jcsm.12745","volume":"12","author":"B Olson","year":"2021","unstructured":"Olson B, Norgard MA, Levasseur PR, Zhu X, Marks DL. Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia. J Cachexia Sarcopenia Muscle. 2021;12:1312\u201332.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"741_CR67","doi-asserted-by":"crossref","unstructured":"Kim H-J, Lee J-H, Kim S-W, Lee S-H, Jung D-W, Williams DR. Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy. PLoS One [Internet]. Public Library of Science; 2021;16:e0252135\u2013e0252135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34038481","DOI":"10.1371\/journal.pone.0252135"},{"key":"741_CR68","doi-asserted-by":"crossref","unstructured":"Shen Q, Kuang J-X, Miao C-X, Zhang W-L, Li Y-W, Zhang X-W, et al. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway. Phytomedicine [Internet]. 2022;95:153858. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0944711321003998","DOI":"10.1016\/j.phymed.2021.153858"},{"key":"741_CR69","doi-asserted-by":"crossref","unstructured":"Bae T, Jang J, Lee H, Song J, Chae S, Park M, et al. Paeonia lactiflora root extract suppresses cancer cachexia by down-regulating muscular NF-\u03baB signalling and muscle-specific E3 ubiquitin ligases in cancer-bearing mice. J Ethnopharmacol [Internet]. 2020;246:112222. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378874119324900","DOI":"10.1016\/j.jep.2019.112222"},{"key":"741_CR70","first-page":"2724","volume":"11","author":"H Lee","year":"2019","unstructured":"Lee H, Heo J-W, Kim A-R, Kweon M, Nam S, Lim J-S, et al. Z-ajoene from crushed garlic alleviates cancer-induced skeletal muscle atrophy. Nutrients [Internet]. MDPI. 2019;11:2724 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31717643.","journal-title":"MDPI"},{"key":"741_CR71","doi-asserted-by":"crossref","unstructured":"Chiappalupi S, Sorci G, Vukasinovic A, Salvadori L, Sagheddu R, Coletti D, et al. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia. J Cachexia Sarcopenia Muscle [Internet]. 2020\/03\/11. John Wiley and Sons Inc.; 2020;11:929\u201346. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32159297","DOI":"10.1002\/jcsm.12561"},{"key":"741_CR72","doi-asserted-by":"crossref","unstructured":"Chen L, Yang Q, Zhang H, Wan L, Xin B, Cao Y, et al. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. J Ethnopharmacol [Internet]. 2020;260:113066. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378874119346847","DOI":"10.1016\/j.jep.2020.113066"},{"key":"741_CR73","doi-asserted-by":"crossref","unstructured":"Liu D, Qiao X, Ge Z, Shang Y, Li Y, Wang W, et al. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Skelet Muscle [Internet]. BioMed Central; 2019;9:8. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30922397","DOI":"10.1186\/s13395-019-0193-2"},{"key":"741_CR74","doi-asserted-by":"crossref","unstructured":"Huot JR, Pin F, Narasimhan A, Novinger LJ, Keith AS, Zimmers TA, et al. ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia. J Cachexia Sarcopenia Muscle [Internet]. 2020\/11\/16. John Wiley and Sons Inc.; 2020;11:1779\u201398. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33200567","DOI":"10.1002\/jcsm.12642"},{"key":"741_CR75","doi-asserted-by":"publisher","unstructured":"Pettersen K, Andersen S, van der Veen A, Nonstad U, Hatakeyama S, Lambert C, et al. Autocrine activin a signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia. J cachexia sarcopenia muscle [internet]. Springer nature; 2020;11:195\u2013207. Available from. https:\/\/doi.org\/10.1002\/jcsm.12489.","DOI":"10.1002\/jcsm.12489"},{"key":"741_CR76","doi-asserted-by":"publisher","unstructured":"Levolger S, Wiemer EAC, van Vugt JLA, Huisman SA, van Vledder MG, van Damme-van Engel S, et al. Inhibition of activin-like kinase 4\/5 attenuates cancer cachexia associated muscle wasting. Sci Rep [Internet]. 2019;9:9826. Available from. https:\/\/doi.org\/10.1038\/s41598-019-46178-9.","DOI":"10.1038\/s41598-019-46178-9"},{"key":"741_CR77","doi-asserted-by":"crossref","unstructured":"Ozawa T, Morikawa M, Morishita Y, Ogikubo K, Itoh F, Koinuma D, et al. Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice. iScience [Internet]. 2021;24:102488. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2589004221004569","DOI":"10.1016\/j.isci.2021.102488"},{"key":"741_CR78","doi-asserted-by":"crossref","unstructured":"Loumaye A, Lause P, Zhong X, Zimmers TA, Bindels LB, Thissen J-P. Activin A causes muscle atrophy through MEF2C-dependent impaired myogenesis. Cells [Internet]. MDPI; 2022;11:1119. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35406681","DOI":"10.3390\/cells11071119"},{"key":"741_CR79","doi-asserted-by":"publisher","unstructured":"Suriben R, Chen M, Higbee J, Oeffinger J, Ventura R, Li B, et al. Antibody-mediated inhibition of GDF15\u2013GFRAL activity reverses cancer cachexia in mice. Nat med [internet]. 2020;26:1264\u201370. Available from. https:\/\/doi.org\/10.1038\/s41591-020-0945-x.","DOI":"10.1038\/s41591-020-0945-x"},{"key":"741_CR80","doi-asserted-by":"crossref","unstructured":"Murphy KT, Hossain MI, Swiderski K, Chee A, Naim T, Trieu J, et al. Mas receptor activation slows tumor growth and attenuates muscle wasting in cancer. Cancer Res [Internet]. 2018\/11\/12. 2019;79:706\u201319. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30420474","DOI":"10.1158\/0008-5472.CAN-18-1207"},{"key":"741_CR81","doi-asserted-by":"crossref","unstructured":"\u2022 Pin F, Huot JR, Bonetto A. The mitochondria-targeting agent MitoQ Improves muscle atrophy, weakness and oxidative metabolism in C26 tumor-bearing mice. Front Cell Dev Biol. 2022;10:1\u201313 In this study, authors reported anti-cachectic properties of mitochondria-targeting antioxidant indicating that prevention of mitochondrial alterations could be a promising tool for the preservation of skeletal mass.","DOI":"10.3389\/fcell.2022.861622"},{"key":"741_CR82","doi-asserted-by":"crossref","unstructured":"Ballar\u00f2 R, Lopalco P, Audrito V, Beltr\u00e0 M, Pin F, Angelini R, et al. Targeting mitochondria by SS-31 ameliorates the whole body energy status in cancer- and chemotherapy-induced cachexia. Cancers. 2021.","DOI":"10.3390\/cancers13040850"},{"key":"741_CR83","doi-asserted-by":"crossref","unstructured":"Wang M, Xia F, Wei Y, Wei X. Molecular mechanisms and clinical management of cancer bone metastasis. Bone Res [Internet]. Nature Publishing Group UK; 2020;8:30. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32793401","DOI":"10.1038\/s41413-020-00105-1"},{"key":"741_CR84","doi-asserted-by":"crossref","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol [Internet]. 2020\/04\/22. Neoplasia Press; 2020;13:100773. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32334405","DOI":"10.1016\/j.tranon.2020.100773"},{"key":"741_CR85","doi-asserted-by":"crossref","unstructured":"Romeo E, Caserta CA, Rumio C, Marcucci F. The vicious cross-talk between tumor cells with an EMT phenotype and cells of the immune system. Cells [Internet]. MDPI; 2019;8:460. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31096701","DOI":"10.3390\/cells8050460"},{"key":"741_CR86","doi-asserted-by":"crossref","unstructured":"Weng Y-S, Tseng H-Y, Chen Y-A, Shen P-C, Al Haq AT, Chen L-M, et al. MCT-1\/miR-34a\/IL-6\/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer [Internet]. BioMed Central; 2019;18:42. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30885232","DOI":"10.1186\/s12943-019-0988-0"},{"key":"741_CR87","doi-asserted-by":"crossref","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-associated macrophages in tumor immunity [internet]. Front. Immunol. 2020. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.583084","DOI":"10.3389\/fimmu.2020.583084"},{"key":"741_CR88","doi-asserted-by":"crossref","unstructured":"Huang R, Wang S, Wang N, Zheng Y, Zhou J, Yang B, et al. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating \u03b2-catenin\/STAT3 signaling. Cell Death Dis [Internet]. Nature Publishing Group UK; 2020;11:234. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32300100","DOI":"10.1038\/s41419-020-2435-y"},{"key":"741_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cmet.2018.12.014","volume":"29","author":"DL Waning","year":"2019","unstructured":"Waning DL, Guise TA, Mohammad KS. A \u201cConnexin\u201d responsible for the fatal attraction of cancer to bone. Cell Metab [Internet]. 2019;29:6\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30625309.","journal-title":"Cell Metab [Internet]"},{"key":"741_CR90","doi-asserted-by":"publisher","unstructured":"Loftus A, Cappariello A, George C, Ucci A, Shefferd K, Green A, et al. Extracellular vesicles from osteotropic breast cancer cells affect bone resident cells. J Bone Miner Res [Internet]. John Wiley & Sons, Ltd; 2020;35:396\u2013412. Available from. https:\/\/doi.org\/10.1002\/jbmr.3891.","DOI":"10.1002\/jbmr.3891"},{"key":"741_CR91","doi-asserted-by":"crossref","unstructured":"\u2022 Yuan X, Qian N, Ling S, Li Y, Sun W, Li J, et al. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Theranostics [Internet]. Ivyspring International Publisher; 2021;11:1429\u201345. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33391543. Authors describe an essential role of breast cancer cell-derived exosomes in promoting bone metastasis by inducing osteoclastogenesis and pre-metastatic niche formation. These exosomes could be a potential target for treatment of breast cancer bone metastasis.","DOI":"10.7150\/thno.45351"},{"key":"741_CR92","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhang S, Liao X, Li M, Chen S, Li X, et al. Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-\u03baB\/bone remodeling factors signaling. Mol Cancer [Internet]. BioMed Central; 2021;20:98. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34325714","DOI":"10.1186\/s12943-021-01394-8"},{"key":"741_CR93","doi-asserted-by":"publisher","unstructured":"Chuang L, In\u00e9s M-J, Tengteng T, Wolfgang W, N. DM, et al. Breast cancer\u2013secreted factors perturb murine bone growth in regions prone to metastasis. Sci Adv [Internet]. Am Assoc Advanc Sci; 2022;7:eabf2283. Available from. https:\/\/doi.org\/10.1126\/sciadv.abf2283.","DOI":"10.1126\/sciadv.abf2283"},{"key":"741_CR94","doi-asserted-by":"crossref","unstructured":"Yue Z, Niu X, Yuan Z, Qin Q, Jiang W, He L, et al. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis. J Clin Invest [Internet]. Am Soc Clin Invest; 2022;132:e144579\u2013e144579. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34847079","DOI":"10.1172\/JCI144579"},{"key":"741_CR95","doi-asserted-by":"publisher","first-page":"115755","DOI":"10.1016\/j.bone.2020.115755","volume":"143","author":"AC Monteiro","year":"2021","unstructured":"Monteiro AC, Bonomo A. Dendritic cells development into osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone consumption. Bone [Internet]. 2021;143:115755 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S8756328220305433.","journal-title":"Bone [Internet]"},{"key":"741_CR96","doi-asserted-by":"crossref","unstructured":"Yadav AS, Pandey PR, Butti R, Radharani NN V, Roy S, Bhalara SR, et al. The biology and therapeutic implications of tumor dormancy and reactivation [internet]. Front. Oncol. 2018. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00072","DOI":"10.3389\/fonc.2018.00072"},{"key":"741_CR97","doi-asserted-by":"crossref","unstructured":"Owen KL, Gearing LJ, Zanker DJ, Brockwell NK, Khoo WH, Roden DL, et al. Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone. EMBO Rep [Internet]. 2020\/04\/21. John Wiley and Sons Inc.; 2020;21:e50162\u2013e50162. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32314873","DOI":"10.15252\/embr.202050162"},{"key":"741_CR98","doi-asserted-by":"crossref","unstructured":"Ren D, Dai Y, Yang Q, Zhang X, Guo W, Ye L, et al. Wnt5a induces and maintains prostate cancer cells dormancy in bone. J Exp med [internet]. 2018\/12\/28. Rockefeller University Press; 2019;216:428\u2013449. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30593464","DOI":"10.1084\/jem.20180661"},{"key":"741_CR99","doi-asserted-by":"crossref","unstructured":"Capulli M, Hristova D, Valbret Z, Carys K, Arjan R, Maurizi A, et al. Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry. Br J cancer [internet]. 2019\/06\/26. Nature Publishing Group UK; 2019;121:157\u2013171. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31239543","DOI":"10.1038\/s41416-019-0501-y"},{"key":"741_CR100","doi-asserted-by":"crossref","unstructured":"Maurizi A, Ciocca M, Giuliani C, Di Carlo I, Teti A. Role of neural (N)-cadherin in breast cancer cell stemness and dormancy in the bone microenvironment. Cancers (Basel) [Internet]. MDPI; 2022;14:1317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35267624","DOI":"10.3390\/cancers14051317"},{"key":"741_CR101","doi-asserted-by":"crossref","unstructured":"Ren Q, Khoo WH, Corr AP, Phan TG, Croucher PI, Stewart SA. Gene expression predicts dormant metastatic breast cancer cell phenotype. Breast Cancer Res [Internet]. BioMed Central; 2022;24:10. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35093137","DOI":"10.1186\/s13058-022-01503-5"},{"key":"741_CR102","doi-asserted-by":"crossref","unstructured":"Carlson P, Dasgupta A, Grzelak CA, Kim J, Barrett A, Coleman IM, et al. Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy. Nat Cell Biol [Internet]. 2019\/01\/21. 2019;21:238\u201350. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30664790","DOI":"10.1038\/s41556-018-0267-0"},{"key":"741_CR103","doi-asserted-by":"crossref","unstructured":"Fox GC, Su X, Davis JL, Xu Y, Kwakwa KA, Ross MH, et al. Targeted therapy to \u03b23 integrin reduces chemoresistance in breast cancer bone metastases. Mol Cancer Ther [Internet]. 2021\/03\/30. 2021;20:1183\u201398. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33785647","DOI":"10.1158\/1535-7163.MCT-20-0931"},{"key":"741_CR104","doi-asserted-by":"crossref","unstructured":"Al-Bari AA, Al Mamun A. Current advances in regulation of bone homeostasis. FASEB bioAdvances [Internet]. John Wiley and Sons Inc.; 2020;2:668\u201379. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33205007","DOI":"10.1096\/fba.2020-00058"},{"key":"741_CR105","doi-asserted-by":"publisher","unstructured":"Zhang X. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer. Cancer Commun [Internet]. 2019;39:76. Available from. https:\/\/doi.org\/10.1186\/s40880-019-0425-1.","DOI":"10.1186\/s40880-019-0425-1"},{"key":"741_CR106","doi-asserted-by":"crossref","unstructured":"Allocca G, Hughes R, Wang N, Brown HK, Ottewell PD, Brown NJ, et al. The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo. J bone Oncol [Internet]. Elsevier; 2019;17:100244. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31236323","DOI":"10.1016\/j.jbo.2019.100244"},{"key":"741_CR107","doi-asserted-by":"crossref","unstructured":"Hughes R, Chen X, Cowley N, Ottewell PD, Hawkins RJ, Hunter KD, et al. Osteoblast-derived paracrine and juxtacrine signals protect disseminated breast cancer cells from stress. Cancers (Basel) [Internet]. MDPI; 2021;13:1366. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33803526","DOI":"10.3390\/cancers13061366"},{"key":"741_CR108","doi-asserted-by":"crossref","unstructured":"Kolb AD, Shupp AB, Mukhopadhyay D, Marini FC, Bussard KM. Osteoblasts are \u201ceducated\u201d by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment. Breast Cancer Res [Internet]. BioMed Central; 2019;21:31. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30813947","DOI":"10.1186\/s13058-019-1117-0"},{"key":"741_CR109","doi-asserted-by":"crossref","unstructured":"Shupp AB, Neupane M, Agostini LC, Ning G, Brody JR, Bussard KM. Stromal-derived extracellular vesicles suppress proliferation of bone metastatic cancer cells mediated by ERK2. Mol Cancer Res [Internet]. 2021\/05\/21. 2021;19:1763\u201377. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34021072","DOI":"10.1158\/1541-7786.MCR-20-0981"},{"key":"741_CR110","doi-asserted-by":"crossref","unstructured":"Haider M-T, Saito H, Zarrer J, Uzhunnumpuram K, Nagarajan S, Kari V, et al. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment. Breast Cancer Res [Internet]. BioMed Central; 2020;22:34. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32272947","DOI":"10.1186\/s13058-020-01269-8"},{"key":"741_CR111","first-page":"544","volume":"11","author":"AS Yamagata","year":"2022","unstructured":"Yamagata AS, Freire PP, Jones Villarinho N, Teles RHG, Francisco KJM, Jaeger RG, et al. Transcriptomic response to acidosis reveals its contribution to bone metastasis in breast cancer cells. Cells [Internet]. MDPI. 2022;11:544 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35159353.","journal-title":"Cells [Internet]. MDPI"},{"key":"741_CR112","doi-asserted-by":"crossref","unstructured":"Di Pompo G, Errani C, Gillies R, Mercatali L, Ibrahim T, Tamanti J, et al. Acid-induced inflammatory cytokines in osteoblasts: a guided path to osteolysis in bone metastasis [Internet]. Front. Cell Dev. Biol. 2021. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2021.678532","DOI":"10.3389\/fcell.2021.678532"},{"key":"741_CR113","first-page":"43","volume":"9","author":"J Back","year":"2021","unstructured":"Back J, Nguyen MN, Li L, Lee S, Lee I, Chen F, et al. Inflammatory conversion of quiescent osteoblasts by metastatic breast cancer cells through pERK1\/2 aggravates cancer-induced bone destruction. Bone Res [Internet]. Nature Publishing Group UK. 2021;9:43 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34588427.","journal-title":"Nature Publishing Group UK"},{"key":"741_CR114","doi-asserted-by":"crossref","unstructured":"Cheng JN, Frye JB, Whitman SA, Kunihiro AG, Pandey R, Funk JL. A Role for TGF\u03b2 signaling in preclinical osteolytic estrogen receptor-positive breast cancer bone metastases progression. Int J Mol Sci [Internet]. MDPI; 2021;22:4463. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33923316","DOI":"10.3390\/ijms22094463"},{"key":"741_CR115","doi-asserted-by":"crossref","unstructured":"Esposito M, Fang C, Cook KC, Park N, Wei Y, Spadazzi C, et al. TGF-\u03b2-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nat Cell Biol [Internet]. 2021\/03\/09. 2021;23:257\u201367. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33723425","DOI":"10.1038\/s41556-021-00641-w"},{"key":"741_CR116","doi-asserted-by":"crossref","unstructured":"Noh J, Yu J, Kim W, Park A, Park K-S. Bone marrow-derived mesenchymal stem cells migrate toward hormone-insensitive prostate tumor cells expressing TGF-\u03b2 via N-cadherin. Biomedicines [Internet]. MDPI; 2021;9:1572. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34829800","DOI":"10.3390\/biomedicines9111572"},{"key":"741_CR117","first-page":"6786","volume":"11","author":"S Choi","year":"2021","unstructured":"Choi S, Yu J, Kim W, Park K-S. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells. Theranostics [internet]. Ivyspring Int Publisher. 2021;11:6786\u201399 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34093853.","journal-title":"Ivyspring Int Publisher"},{"key":"741_CR118","doi-asserted-by":"publisher","unstructured":"Siddiqui JA, Seshacharyulu P, Muniyan S, Pothuraju R, Khan P, Vengoji R, et al. GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation. Bone Res [Internet]. 2022;10:6. Available from. https:\/\/doi.org\/10.1038\/s41413-021-00178-6.","DOI":"10.1038\/s41413-021-00178-6"},{"key":"741_CR119","doi-asserted-by":"publisher","unstructured":"Wang W, Yang X, Dai J, Lu Y, Zhang J, Keller ET. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion. Oncogene [Internet]. 2019;38:4540\u201359. Available from. https:\/\/doi.org\/10.1038\/s41388-019-0736-3.","DOI":"10.1038\/s41388-019-0736-3"},{"key":"741_CR120","doi-asserted-by":"crossref","unstructured":"Ye L, Jiang WG. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies. Cancer Lett [Internet]. 2016;380:586\u201397. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304383515007041","DOI":"10.1016\/j.canlet.2015.10.036"},{"key":"741_CR121","doi-asserted-by":"publisher","unstructured":"Sun Z, Cai S, Zabkiewicz C, Liu C, Ye L. Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review). Int J Oncol [Internet]. VIP-II Division of Medical Department, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China Cardiff China Medical Research Collaborative; 2020;56:1335\u201351. Available from: https:\/\/doi.org\/10.3892\/ijo.2020.5030","DOI":"10.3892\/ijo.2020.5030"},{"key":"741_CR122","doi-asserted-by":"crossref","unstructured":"Ihle CL, Straign DM, Provera MD, Novitskiy S V, Owens P. Loss of myeloid BMPR1a alters differentiation and reduces mouse prostate cancer growth. Front Oncol [Internet]. Frontiers Media S.A.; 2020;10:357. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32318332","DOI":"10.3389\/fonc.2020.00357"},{"key":"741_CR123","doi-asserted-by":"crossref","unstructured":"Gooding S, Olechnowicz SWZ, Morris E V, Armitage AE, Arezes J, Frost J, et al. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease. Nat Commun [Internet]. Nature Publishing Group UK; 2019;10:4533. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31586071","DOI":"10.1038\/s41467-019-12296-1"},{"key":"741_CR124","doi-asserted-by":"crossref","unstructured":"Straign DM, Ihle CL, Provera MD, Owens P. Targeting the BMP pathway in prostate cancer induced bone disease [internet]. Front. Endocrinol. . 2021. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2021.769316","DOI":"10.3389\/fendo.2021.769316"},{"key":"741_CR125","doi-asserted-by":"crossref","unstructured":"Bach D-H, Park HJ, Lee SK. The dual role of bone morphogenetic proteins in cancer. Mol Ther oncolytics [Internet]. Am Soc Gene Cell Ther. 2017;8:1\u201313. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29234727","DOI":"10.1016\/j.omto.2017.10.002"},{"key":"741_CR126","doi-asserted-by":"crossref","unstructured":"Vollaire J, Machuca-Gayet I, Lavaud J, Bellanger A, Bouazza L, El Moghrabi S, et al. The bone morphogenetic protein signaling inhibitor LDN-193189 enhances metastasis development in mice [internet]. Front. Pharmacol. . 2019. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00667","DOI":"10.3389\/fphar.2019.00667"},{"key":"741_CR127","doi-asserted-by":"crossref","unstructured":"Monteran L, Ershaid N, Sabah I, Fahoum I, Zait Y, Shani O, et al. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis. Sci Rep [Internet]. Nature Publishing Group UK; 2020;10:13838. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32796899","DOI":"10.1038\/s41598-020-70788-3"},{"key":"741_CR128","doi-asserted-by":"crossref","unstructured":"Kfoury Y, Baryawno N, Severe N, Mei S, Gustafsson K, Hirz T, et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell [Internet]. 2021;39:1464-1478.e8. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610821004943","DOI":"10.1016\/j.ccell.2021.09.005"},{"key":"741_CR129","doi-asserted-by":"publisher","unstructured":"Ma R-Y, Zhang H, Li X-F, Zhang C-B, Selli C, Tagliavini G, et al. Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth. J Exp Med [Internet]. 2020;217:e20191820. Available from. https:\/\/doi.org\/10.1084\/jem.20191820.","DOI":"10.1084\/jem.20191820"},{"key":"741_CR130","doi-asserted-by":"crossref","unstructured":"Lin Q, Fang X, Liang G, Luo Q, Cen Y, Shi Y, et al. Silencing CTNND1 mediates triple-negative breast cancer bone metastasis via upregulating CXCR4\/CXCL12 axis and neutrophils infiltration in bone. Cancers (Basel) [Internet]. MDPI; 2021;13:5703. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34830862","DOI":"10.3390\/cancers13225703"},{"key":"741_CR131","doi-asserted-by":"crossref","unstructured":"Costanzo-Garvey DL, Keeley T, Case AJ, Watson GF, Alsamraae M, Yu Y, et al. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunol Immunother [internet]. 2020\/02\/29. Springer Berlin Heidelberg; 2020;69:1113\u20131130. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32114681","DOI":"10.1007\/s00262-020-02527-6"},{"key":"741_CR132","doi-asserted-by":"publisher","unstructured":"Bouchet M, Lain\u00e9 A, Boyault C, Proponnet-Guerault M, Meugnier E, Bouazza L, et al. ERR\u03b1 expression in bone metastases leads to an exacerbated antitumor immune response. Cancer Res [Internet]. 2020;80:2914\u201326. Available from. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3584.","DOI":"10.1158\/0008-5472.CAN-19-3584"},{"key":"741_CR133","doi-asserted-by":"crossref","unstructured":"Li F, Du X, Lan F, Li N, Zhang C, Zhu C, et al. Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth. Sci Adv [Internet]. American Association for the Advancement of Science; 2021;7:eabb5943\u2013eabb5943. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34039594","DOI":"10.1126\/sciadv.abb5943"},{"key":"741_CR134","doi-asserted-by":"crossref","unstructured":"Haider M-T, Ridlmaier N, Smit DJ, Taipaleenm\u00e4ki H. Interleukins as mediators of the tumor cell-bone cell crosstalk during the initiation of breast cancer bone metastasis. Int J Mol Sci [Internet]. MDPI; 2021;22:2898. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33809315","DOI":"10.3390\/ijms22062898"},{"key":"741_CR135","doi-asserted-by":"crossref","unstructured":"Liang M, Ma Q, Ding N, Luo F, Bai Y, Kang F, et al. IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis. Cell Death Dis [Internet]. Nature Publishing Group UK; 2019;10:353. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31040267","DOI":"10.1038\/s41419-019-1594-1"},{"key":"741_CR136","doi-asserted-by":"crossref","unstructured":"Jin Q, Yang H, Jing Z, Hong-Hua W, Ben-Jing S, Li-Ting W, et al. IL4\/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors. Mol Med [Internet]. BioMed Central; 2021;27:152. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34863091","DOI":"10.1186\/s10020-021-00411-2"},{"key":"741_CR137","doi-asserted-by":"publisher","unstructured":"Eyre R, Alf\u00e9rez DG, Santiago-G\u00f3mez A, Spence K, McConnell JC, Hart C, et al. Microenvironmental IL1\u03b2 promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Nat Commun [Internet]. 2019;10:5016. Available from. https:\/\/doi.org\/10.1038\/s41467-019-12807-0.","DOI":"10.1038\/s41467-019-12807-0"},{"key":"741_CR138","doi-asserted-by":"publisher","unstructured":"Tulotta C, Lefley DV, Freeman K, Gregory WM, Hanby AM, Heath PR, et al. Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment. Clin Cancer Res [Internet]. 2019;25:2769\u20132782. Available from. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2202.","DOI":"10.1158\/1078-0432.CCR-18-2202"},{"key":"741_CR139","unstructured":"Zhao C, Cai X, Wang Y, Wang D, Wang T, Gong H, et al. NAT1 promotes osteolytic metastasis in luminal breast cancer by regulating the bone metastatic niche via NF-\u03baB\/IL-1B signaling pathway. Am J Cancer Res [Internet]. e-Century Publishing Corporation; 2020;10:2464\u201379. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32905535"},{"key":"741_CR140","doi-asserted-by":"crossref","unstructured":"Tulotta C, Lefley D V, Moore CK, Amariutei AE, Spicer-Hadlington AR, Quayle LA, et al. IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. NPJ breast cancer [Internet]. Nature Publishing Group UK; 2021;7:95. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34290237","DOI":"10.1038\/s41523-021-00305-w"},{"key":"741_CR141","doi-asserted-by":"crossref","unstructured":"McGuire JJ, Frieling JS, Lo CH, Li T, Muhammad A, Lawrence HR, et al. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nat Commun [Internet]. Nature Publishing Group UK; 2021;12:723. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33526787","DOI":"10.1038\/s41467-021-20962-6"},{"key":"741_CR142","doi-asserted-by":"crossref","unstructured":"Romero-Moreno R, Curtis KJ, Coughlin TR, Miranda-Vergara MC, Dutta S, Natarajan A, et al. The CXCL5\/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis. Nat Commun [Internet]. Nature Publishing Group UK; 2019;10:4404. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31562303","DOI":"10.1038\/s41467-019-12108-6"},{"key":"741_CR143","doi-asserted-by":"publisher","unstructured":"Furesi G, Rauner M, Hofbauer LC. Emerging players in prostate cancer&#x2013;Bone Niche Communication. Trends in Cancer [Internet]. Elsevier; 2021;7:112\u201321. Available from: https:\/\/doi.org\/10.1016\/j.trecan.2020.09.006","DOI":"10.1016\/j.trecan.2020.09.006"},{"key":"741_CR144","doi-asserted-by":"crossref","unstructured":"Probert C, Dottorini T, Speakman A, Hunt S, Nafee T, Fazeli A, et al. Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis. Oncogene [internet]. 2018\/10\/23. Nature Publishing Group UK; 2019;38:1751\u20131763. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30353168","DOI":"10.1038\/s41388-018-0540-5"},{"key":"741_CR145","doi-asserted-by":"crossref","unstructured":"Giannandrea D, Citro V, Lesma E, Bignotto M, Platonova N, Chiaramonte R. Restoring tissue homeostasis at metastatic sites: a focus on extracellular vesicles in bone metastasis. Front Oncol [Internet]. Frontiers Media S.A.; 2021;11:644109. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33869035","DOI":"10.3389\/fonc.2021.644109"},{"key":"741_CR146","doi-asserted-by":"crossref","unstructured":"Henrich SE, McMahon KM, Plebanek MP, Calvert AE, Feliciano TJ, Parrish S, et al. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner. J Extracell vesicles [Internet]. 2020\/12\/31. John Wiley and Sons Inc.; 2020;10:e12042\u2013e12042. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33408816","DOI":"10.1002\/jev2.12042"},{"key":"741_CR147","doi-asserted-by":"crossref","unstructured":"Hu C-Y, Chen J, Qin X-H, You P, Ma J, Zhang J, et al. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer. J Exp Clin Cancer Res [Internet]. BioMed Central; 2021;40:98. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33722248","DOI":"10.1186\/s13046-021-01891-0"},{"key":"741_CR148","doi-asserted-by":"publisher","unstructured":"Dai J, Escara-Wilke J, Keller JM, Jung Y, Taichman RS, Pienta KJ, et al. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis. J Exp Med [Internet]. 2019;216:2883\u201399. Available from. https:\/\/doi.org\/10.1084\/jem.20190158.","DOI":"10.1084\/jem.20190158"},{"key":"741_CR149","doi-asserted-by":"crossref","unstructured":"Raimondi L, De Luca A, Fontana S, Amodio N, Costa V, Carina V, et al. Multiple myeloma-derived extracellular vesicles induce osteoclastogenesis through the activation of the XBP1\/IRE1\u03b1 Axis. Cancers (Basel) [Internet]. MDPI; 2020;12:2167. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32759820","DOI":"10.3390\/cancers12082167"},{"key":"741_CR150","doi-asserted-by":"crossref","unstructured":"Raimondo S, Saieva L, Vicario E, Pucci M, Toscani D, Manno M, et al. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis. J Hematol Oncol [Internet]. BioMed Central; 2019;12:2. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30621731","DOI":"10.1186\/s13045-018-0689-y"},{"key":"741_CR151","doi-asserted-by":"crossref","unstructured":"Bravo V\u00e1zquez LA, Moreno Becerril MY, Mora Hern\u00e1ndez EO, Le\u00f3n Carmona GG de, Aguirre Padilla ME, Chakraborty S, et al. The emerging role of MicroRNAs in bone diseases and their therapeutic potential. Molecules [Internet]. MDPI; 2021;27:211. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35011442","DOI":"10.3390\/molecules27010211"},{"key":"741_CR152","doi-asserted-by":"publisher","unstructured":"Puppo M, Taipaleenm\u00e4ki H, Hesse E, Cl\u00e9zardin P. Non-coding RNAs in bone remodelling and bone metastasis: mechanisms of action and translational relevance. Br J Pharmacol [internet]. John Wiley & Sons, ltd; 2021;178:1936\u201354. Available from. https:\/\/doi.org\/10.1111\/bph.14836.","DOI":"10.1111\/bph.14836"},{"key":"741_CR153","doi-asserted-by":"crossref","unstructured":"Guo L, Zhu Y, Li L, Zhou S, Yin G, Yu G, et al. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1. Cancer Med [Internet]. 2019\/08\/06. John Wiley and Sons Inc.; 2019;8:5687\u2013701. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31385464","DOI":"10.1002\/cam4.2454"},{"key":"741_CR154","doi-asserted-by":"crossref","unstructured":"Wang S, Liu Z, Wang J, Ji X, Yao Z, Wang X. miR-21 promotes osteoclastogenesis through activation of PI3K\/Akt signaling by targeting Pten in RAW264.7 cells. Mol Med Rep [Internet]. 2020\/01\/13. D.A. Spandidos; 2020;21:1125\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32016444","DOI":"10.3892\/mmr.2020.10938"},{"key":"741_CR155","doi-asserted-by":"publisher","unstructured":"Kitayama K, Kawamoto T, Kawakami Y, Hara H, Takemori T, Fujiwara S, et al. Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis. Int J Oncol [internet]. Department of Orthopaedic Surgery, Kobe University graduate School of Medicine, Kobe, Hyogo 650-0017, Japan; 2021;59:97. Available from. https:\/\/doi.org\/10.3892\/ijo.2021.5277.","DOI":"10.3892\/ijo.2021.5277"},{"key":"741_CR156","doi-asserted-by":"crossref","unstructured":"Furesi G, de Jesus Domingues AM, Alexopoulou D, Dahl A, Hackl M, Schmidt JR, et al. Exosomal miRNAs from prostate cancer impair osteoblast function in mice. Int J Mol Sci [Internet]. MDPI; 2022;23:1285. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35163219","DOI":"10.3390\/ijms23031285"},{"key":"741_CR157","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbrc.2021.12.075","volume":"594","author":"Z Sun","year":"2022","unstructured":"Sun Z, Hu J, Ren W, Fang Y, Hu K, Yu H, et al. LncRNA SNHG3 regulates the BMSC osteogenic differentiation in bone metastasis of breast cancer by modulating the miR-1273g-3p\/BMP3 axis. Biochem Biophys Res Commun [Internet]. 2022;594:117\u201323 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006291X21017162.","journal-title":"Biochem Biophys Res Commun [Internet]."},{"key":"741_CR158","doi-asserted-by":"crossref","unstructured":"Chen L, Wang Y, Lu X, Zhang L, Wang Z. miRNA-7062-5p promoting bone resorption after bone metastasis of colorectal cancer through inhibiting GPR65 [Internet]. Front. Cell Dev. Biol. 2021. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2021.681968","DOI":"10.3389\/fcell.2021.681968"},{"key":"741_CR159","doi-asserted-by":"crossref","unstructured":"Kim B, Jung S, Kim H, Kwon J-O, Song M-K, Kim MK, et al. The role of S100A4 for bone metastasis in prostate cancer cells. BMC Cancer [Internet]. BioMed Central; 2021;21:137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33549040","DOI":"10.1186\/s12885-021-07850-4"},{"key":"741_CR160","doi-asserted-by":"crossref","unstructured":"Kim H, Kim B, Il Kim S, Kim HJ, Ryu BY, Chung J, et al. S100A4 released from highly bone-metastatic breast cancer cells plays a critical role in osteolysis. Bone Res [Internet]. Nature Publishing Group UK; 2019;7:30. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31667000","DOI":"10.1038\/s41413-019-0068-5"},{"key":"741_CR161","doi-asserted-by":"publisher","unstructured":"Chengling L, Yulin Z, Xiaoyu X, Xingchen L, Sen Z, Ziming W, et al. miR-325-3p, a novel regulator of osteoclastogenesis in osteolysis of colorectal cancer through targeting S100A4. Mol med [internet]. 2021;27:23. Available from. https:\/\/doi.org\/10.1186\/s10020-021-00282-7.","DOI":"10.1186\/s10020-021-00282-7"},{"key":"741_CR162","doi-asserted-by":"crossref","unstructured":"Li Y, Liang Y, Ma T, Yang Q. Identification of DGUOK-AS1 as a prognostic factor in breast cancer by bioinformatics analysis. Front Oncol [Internet]. Frontiers Media S.A.; 2020;10:1092. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32766141","DOI":"10.3389\/fonc.2020.01092"},{"key":"741_CR163","doi-asserted-by":"crossref","unstructured":"Zhang L, Niu H, Yang P, Ma J, Yuan B-Y, Zeng Z-C, et al. Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients. BMC Cancer [Internet]. BioMed Central; 2021;21:161. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33588789","DOI":"10.1186\/s12885-021-07808-6"},{"key":"741_CR164","doi-asserted-by":"crossref","unstructured":"Chen Y, Chen Z, Mo J, Pang M, Chen Z, Feng F, et al. Identification of HCG18 and MCM3AP-AS1 that associate with bone metastasis, poor prognosis and increased abundance of M2 macrophage infiltration in prostate cancer. Technol Cancer Res Treat [Internet]. SAGE Publications; 2021;20:1533033821990064\u20131533033821990064. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33596783","DOI":"10.1177\/1533033821990064"},{"key":"741_CR165","doi-asserted-by":"crossref","unstructured":"Wang Y, Fang Y-X, Dong B, Du X, Wang J, Wang X, et al. Discovery of extracellular vesicles derived miR-181a-5p in patient\u2019s serum as an indicator for bone-metastatic prostate cancer. Theranostics [internet]. Ivyspring International Publisher; 2021;11:878\u2013892. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33391510","DOI":"10.7150\/thno.49186"},{"key":"741_CR166","doi-asserted-by":"crossref","unstructured":"Olivan M, Garcia M, Su\u00e1rez L, Guiu M, Gros L, M\u00e9ndez O, et al. Loss of microRNA-135b enhances bone metastasis in prostate cancer and predicts aggressiveness in human prostate samples. Cancers (Basel) [Internet]. MDPI; 2021;13:6202. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34944822","DOI":"10.3390\/cancers13246202"},{"key":"741_CR167","doi-asserted-by":"publisher","unstructured":"Liang Y, Ye F, Wang Y, Li Y, Li Y, Song X, et al. DGUOK-AS1 acts as a tumor promoter through regulating miR-204-5p\/IL-11 axis in breast cancer. Mol Ther - nucleic acids [internet]. Elsevier; 2021;26:1079\u201391. Available from. https:\/\/doi.org\/10.1016\/j.omtn.2021.10.018.","DOI":"10.1016\/j.omtn.2021.10.018"},{"key":"741_CR168","doi-asserted-by":"crossref","unstructured":"Wa Q, Zou C, Lin Z, Huang S, Peng X, Yang C, et al. Ectopic expression of miR-532-3p suppresses bone metastasis of prostate cancer cells via inactivating NF-\u03baB signaling. Mol Ther oncolytics [Internet]. Am Soc Gene Cell Therapy; 2020;17:267\u201377. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32368615","DOI":"10.1016\/j.omto.2020.03.024"},{"key":"741_CR169","doi-asserted-by":"crossref","unstructured":"Wa Q, Huang S, Pan J, Tang Y, He S, Fu X, et al. miR-204-5p represses bone metastasis via inactivating NF-\u03baB signaling in prostate cancer. Mol Ther Nucleic Acids [Internet]. 2019\/09\/18. Am Soc Gene Cell Ther; 2019;18:567\u201379. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31678733","DOI":"10.1016\/j.omtn.2019.09.008"},{"key":"741_CR170","doi-asserted-by":"crossref","unstructured":"Huang S, Zou C, Tang Y, Wa Q, Peng X, Chen X, et al. miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-\u03b2 signaling. Mol Ther Nucleic Acids [Internet]. 2019\/01\/15. Am Soc Gene Cell Ther; 2019;16:91\u2013104. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30852380","DOI":"10.1016\/j.omtn.2019.01.004"},{"key":"741_CR171","first-page":"6063","volume":"9","author":"Y Dai","year":"2019","unstructured":"Dai Y, Wu Z, Lang C, Zhang X, He S, Yang Q, et al. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-\u03b2 signaling. Theranostics [internet]. Ivyspring International Publisher. 2019;9:6063\u201379 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31534537.","journal-title":"Ivyspring International Publisher"},{"key":"741_CR172","doi-asserted-by":"crossref","unstructured":"Wang J, Du X, Wang X, Xiao H, Jing N, Xue W, et al. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a\/Nfatc1\/Angptl2 axis for bone metastasis. Cancer Lett [Internet]. 2022;526:76\u201390. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S030438352100584X","DOI":"10.1016\/j.canlet.2021.11.017"},{"key":"741_CR173","doi-asserted-by":"publisher","unstructured":"Ma Q, Liang M, Wu Y, Dou C, Xu J, Dong S, et al. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche. J Extracell vesicles [internet]. John Wiley & Sons, Ltd; 2021;10:e12068. Available from. https:\/\/doi.org\/10.1002\/jev2.12068.","DOI":"10.1002\/jev2.12068"},{"key":"741_CR174","doi-asserted-by":"crossref","unstructured":"Zhang L, Niu H, Ma J, Yuan B-Y, Chen Y-H, Zhuang Y, et al. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. Mol Cancer [Internet]. BioMed Central; 2019;18:120. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31349837","DOI":"10.1186\/s12943-019-1044-9"},{"key":"741_CR175","doi-asserted-by":"crossref","unstructured":"Ni J, Zhang X, Li J, Zheng Z, Zhang J, Zhao W, et al. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p\/RAC1 signalling axis in osteoclasts. Cell Death Dis [Internet]. Nature Publishing Group UK; 2021;12:662. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34215717","DOI":"10.1038\/s41419-021-04399-9"},{"key":"741_CR176","doi-asserted-by":"crossref","unstructured":"Safarulla S, Khillar PS, Kini S, Jaiswal AK. Tissue engineered scaffolds as 3D models for prostate cancer metastasis to bone. Mater Today Commun [Internet]. 2021;28:102641. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352492821006334","DOI":"10.1016\/j.mtcomm.2021.102641"},{"key":"741_CR177","doi-asserted-by":"crossref","unstructured":"Hughes AM, Kolb AD, Shupp AB, Shine KM, Bussard KM. Printing the pathway forward in bone metastatic cancer research: applications of 3D engineered models and bioprinted scaffolds to recapitulate the bone-tumor niche. Cancers (Basel) [Internet]. MDPI; 2021;13:507. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33572757","DOI":"10.3390\/cancers13030507"},{"key":"741_CR178","doi-asserted-by":"crossref","unstructured":"Lee S, Mendoza TR, Burner DN, Muldong MT, Wu CCN, Arreola-Villanueva C, et al. Novel dormancy mechanism of castration resistance in bone metastatic prostate cancer organoids. Int J Mol Sci [Internet]. MDPI; 2022;23:3203. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35328625","DOI":"10.3390\/ijms23063203"},{"key":"741_CR179","doi-asserted-by":"crossref","unstructured":"Laranga R, Duchi S, Ibrahim T, Guerrieri AN, Donati DM, Lucarelli E. Trends in bone metastasis modeling. Cancers (Basel) [Internet]. MDPI; 2020;12:2315. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32824479","DOI":"10.3390\/cancers12082315"},{"key":"741_CR180","doi-asserted-by":"crossref","unstructured":"Brylka L, J\u00e4hn-Rickert K, Baranowsky A, Neven M, Horn M, Yorgan T, et al. Spine metastases in immunocompromised mice after intracardiac injection of MDA-MB-231-SCP2 breast cancer cells. Cancers (Basel) [Internet]. MDPI; 2022;14:556. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35158823","DOI":"10.3390\/cancers14030556"},{"key":"741_CR181","doi-asserted-by":"crossref","unstructured":"Rimal R, Desai P, Marquez AB, Sieg K, Marquardt Y, Singh S. 3-D vascularized breast cancer model to study the role of osteoblast in formation of a pre-metastatic niche. Sci Rep [Internet]. Nature Publishing Group UK; 2021;11:21966. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34754042","DOI":"10.1038\/s41598-021-01513-x"},{"key":"741_CR182","doi-asserted-by":"publisher","unstructured":"Lefley D, Howard F, Arshad F, Bradbury S, Brown H, Tulotta C, et al. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts. Breast cancer res [internet]. 2019;21:130. Available from. https:\/\/doi.org\/10.1186\/s13058-019-1220-2.","DOI":"10.1186\/s13058-019-1220-2"},{"key":"741_CR183","doi-asserted-by":"publisher","unstructured":"Han Y, Nakayama J, Hayashi Y, Jeong S, Futakuchi M, Ito E, et al. Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection. Genes to cells [internet]. John Wiley & Sons, ltd; 2020;25:111\u201323. Available from. https:\/\/doi.org\/10.1111\/gtc.12743.","DOI":"10.1111\/gtc.12743"},{"key":"741_CR184","doi-asserted-by":"publisher","unstructured":"Bock N, Shokoohmand A, Kryza T, R\u00f6hl J, Meijer J, Tran PA, et al. Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment. Bone res [internet]. 2019;7:13. Available from. https:\/\/doi.org\/10.1038\/s41413-019-0049-8.","DOI":"10.1038\/s41413-019-0049-8"},{"key":"741_CR185","doi-asserted-by":"publisher","unstructured":"Nathalie B, Thomas K, Ali S, Joan R, Akhilandeshwari R, Marie-Luise W, et al. In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer. Sci Adv [internet]. American Association for the Advancement of Science; 2022;7:eabg2564. Available from. https:\/\/doi.org\/10.1126\/sciadv.abg2564.","DOI":"10.1126\/sciadv.abg2564"},{"key":"741_CR186","doi-asserted-by":"crossref","unstructured":"Jiang W, Rixiati Y, Huang H, Shi Y, Huang C, Jiao B. Asperolide A prevents bone metastatic breast cancer via the PI3K\/AKT\/mTOR\/c-Fos\/NFATc1 signaling pathway. Cancer Med [Internet]. 2020\/09\/25. John Wiley and Sons Inc.; 2020;9:8173\u201385. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32976685","DOI":"10.1002\/cam4.3432"},{"key":"741_CR187","doi-asserted-by":"crossref","unstructured":"Li T, Jiang G, Hu X, Yang D, Tan T, Gao Z, et al. Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-\u03baB signaling pathway of osteoclasts [internet]. Front. Pharmacol. . 2021. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2021.789552","DOI":"10.3389\/fphar.2021.789552"},{"key":"741_CR188","doi-asserted-by":"publisher","unstructured":"Nakai Y, Okamoto K, Terashima A, Ehata S, Nishida J, Imamura T, et al. Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis. Bone res [internet]. 2019;7:1. Available from. https:\/\/doi.org\/10.1038\/s41413-018-0036-5.","DOI":"10.1038\/s41413-018-0036-5"},{"key":"741_CR189","doi-asserted-by":"crossref","unstructured":"Bishop RT, Marino S, Carrasco G, Li B, Allen RJ, Sparatore A, et al. Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis. Cancer Lett [Internet]. 2020;488:27\u201339. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304383520302822","DOI":"10.1016\/j.canlet.2020.05.021"},{"key":"741_CR190","doi-asserted-by":"crossref","unstructured":"Pantano F, Croset M, Driouch K, Bednarz-Knoll N, Iuliani M, Ribelli G, et al. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene [internet]. 2021\/01\/08. Nature Publishing Group UK; 2021;40:1284\u20131299. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33420367","DOI":"10.1038\/s41388-020-01603-6"},{"key":"741_CR191","doi-asserted-by":"crossref","unstructured":"Kunihiro AG, Brickey JA, Frye JB, Cheng JN, Luis PB, Schneider C, et al. Curcumin inhibition of TGF\u03b2 signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites. J Nutr Biochem [Internet]. 2022;99:108842. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S095528632100262X","DOI":"10.1016\/j.jnutbio.2021.108842"},{"key":"741_CR192","doi-asserted-by":"crossref","unstructured":"Kunihiro AG, Brickey JA, Frye JB, Luis PB, Schneider C, Funk JL. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGF\u03b2-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues. J Nutr Biochem [Internet]. 2018\/10\/11. 2019;63:150\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30393127","DOI":"10.1016\/j.jnutbio.2018.09.021"},{"key":"741_CR193","doi-asserted-by":"publisher","unstructured":"Zhang N, Su P, Li X, Xi J, Li X, Xu L. Downregulated Kr\u00fcppel-like factor 4 expression is associated with the aggressiveness of prostate cancer . Oncol Rep [Internet]. Department of Urology, The Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563003, P.R. China; 2019;41:1789\u201396. Available from: https:\/\/doi.org\/10.3892\/or.2019.6975","DOI":"10.3892\/or.2019.6975"},{"key":"741_CR194","doi-asserted-by":"crossref","unstructured":"Liang H, Chen Q, Hu Z, Zhou L, Meng Q, Zhang T, et al. Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis. Ann Transl Med [Internet]. AME Publishing Company; 2022;10:281. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35434017","DOI":"10.21037\/atm-22-764"},{"key":"741_CR195","doi-asserted-by":"crossref","unstructured":"Huang F, Cao Y, Wang C, Lan R, Wu B, Xie X, et al. PNMA5 Promotes Bone Metastasis of Non-small-Cell Lung Cancer as a Target of BMP2 Signaling. Front cell Dev Biol [Internet]. Frontiers Media S.A.; 2021;9:678931. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34136487","DOI":"10.3389\/fcell.2021.678931"},{"key":"741_CR196","doi-asserted-by":"crossref","unstructured":"Qian J, Gong Z-C, Zhang Y-N, Wu H-H, Zhao J, Wang L-T, et al. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer. Cell Commun Signal [Internet]. BioMed Central; 2021;19:9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33478523","DOI":"10.1186\/s12964-020-00667-x"},{"key":"741_CR197","first-page":"361","volume":"147","author":"M Kovacheva","year":"2021","unstructured":"Kovacheva M, Zepp M, Berger S, Berger MR. Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis. J cancer res Clin Oncol [internet]. 2020\/10\/20. Springer. Berlin Heidelberg. 2021;147:361\u201371 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33083904.","journal-title":"Berlin Heidelberg"},{"key":"741_CR198","doi-asserted-by":"crossref","unstructured":"Tiedemann K, Sadvakassova G, Mikolajewicz N, Juhas M, Sabirova Z, Tabari\u00e8s S, et al. Exosomal release of L-plastin by breast cancer cells facilitates metastatic bone osteolysis. Transl Oncol [internet]. 2018\/12\/21. Neoplasia Press; 2019;12:462\u2013474. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30583289","DOI":"10.1016\/j.tranon.2018.11.014"},{"key":"741_CR199","doi-asserted-by":"crossref","unstructured":"Guerrieri AN, Montesi M, Sprio S, Laranga R, Mercatali L, Tampieri A, et al. Innovative options for bone metastasis treatment: an extensive analysis on biomaterials-based strategies for orthopedic surgeons [internet]. Front. Bioeng. Biotechnol. 2020. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.589964","DOI":"10.3389\/fbioe.2020.589964"},{"key":"741_CR200","volume-title":"Li B-Y, et al","author":"S-Z Liu","year":"2021","unstructured":"Liu S-Z, Sun X, Li K-X, Lin C-C, Na S. Li B-Y, et al. Onco: Tumor cell secretomes in response to anti- and pro-tumorigenic agents; 2021."},{"key":"741_CR201","doi-asserted-by":"crossref","unstructured":"Liu S, Wu D, Sun X, Fan Y, Zha R, Jalali A, et al. Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone. Bone Res [Internet]. Nature Publishing Group UK; 2021;9:32. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34230453","DOI":"10.1038\/s41413-021-00152-2"},{"key":"741_CR202","doi-asserted-by":"crossref","unstructured":"Sano T, Sun X, Feng Y, Liu S, Hase M, Fan Y, et al. Inhibition of the growth of breast cancer-associated brain tumors by the osteocyte-derived conditioned medium. Cancers (Basel) [Internet]. MDPI; 2021;13:1061. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33802279","DOI":"10.3390\/cancers13051061"},{"key":"741_CR203","first-page":"5143","volume":"11","author":"X Sun","year":"2021","unstructured":"Sun X, Li K, Zha R, Liu S, Fan Y, Wu D, et al. Preventing tumor progression to the bone by induced tumor-suppressing MSCs. Theranostics [Internet]. Ivyspring International Publisher. 2021;11:5143\u201359 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33859739.","journal-title":"Ivyspring International Publisher"},{"key":"741_CR204","doi-asserted-by":"crossref","unstructured":"Li K-X, Sun X, Li B-Y, Yokota H. Conversion of osteoclasts into bone-protective, tumor-suppressing cells. Cancers (Basel) [Internet]. MDPI; 2021;13:5593. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34830748","DOI":"10.3390\/cancers13225593"},{"key":"741_CR205","doi-asserted-by":"crossref","unstructured":"\u2022 Sun X, Li K, Hase M, Zha R, Feng Y, Li B-Y, et al. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1\/moesin-mediated inhibition of TGF\u03b2\/FN1\/CD44 signaling. Theranostics [Internet]. Ivyspring International Publisher; 2022;12:929\u201343. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34976221. In most recent study, authors suggest that activation of WNT signaling generates tumor-suppressive and bone-protective secretomes derived by osteoblasts. This has a potential for developing secretome-based therapy for breast cancer-associated bone metastasis.","DOI":"10.7150\/thno.66148"},{"key":"741_CR206","first-page":"8517","volume":"11","author":"S Liu","year":"2021","unstructured":"Liu S, Sun X, Li K, Zha R, Feng Y, Sano T, et al. Generation of the tumor-suppressive secretome from tumor cells. Theranostics [internet]. Ivyspring Int Publisher. 2021;11:8517\u201334 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34373756.","journal-title":"Ivyspring Int Publisher"},{"key":"741_CR207","doi-asserted-by":"publisher","unstructured":"Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, et al. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Discov [internet]. 2022;8:35. Available from. https:\/\/doi.org\/10.1038\/s41421-022-00387-1.","DOI":"10.1038\/s41421-022-00387-1"},{"key":"741_CR208","doi-asserted-by":"crossref","unstructured":"Zhang X, Liu Q, Zhang T, Gao P, Wang H, Yao L, et al. Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment. Drug Deliv [Internet]. Taylor Francis; 2022;29:889\u2013905. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35285760","DOI":"10.1080\/10717544.2022.2050845"},{"key":"741_CR209","doi-asserted-by":"crossref","unstructured":"Bai S, Liu D, Cheng Y, Cui H, Liu M, Cui M, et al. Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer. Nanomedicine Nanotechnology, Biol Med [Internet]. 2019;21:102054. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1549963419301388","DOI":"10.1016\/j.nano.2019.102054"},{"key":"741_CR210","doi-asserted-by":"crossref","unstructured":"Huang Y, Xiao Z, Guan Z, Zeng Z, Shen Y, Xu X, et al. Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption. Acta pharm Sin B [internet]. 2020\/06\/19. Elsevier; 2020;10:2384\u20132403. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33354509","DOI":"10.1016\/j.apsb.2020.06.006"},{"key":"741_CR211","doi-asserted-by":"crossref","unstructured":"Zhang Z, Yao Y, Yuan Q, Lu C, Zhang X, Yuan J, et al. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis. Theranostics [internet]. Ivyspring International Publisher; 2020;10:4042\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32226538","DOI":"10.7150\/thno.42218"},{"key":"741_CR212","unstructured":"\u2022\u2022 Pin F, Jones AJ, Huot JR, Narasimhan A, Zimmers TA, Bonewald LF, et al. RANKL blockade reduces cachexia and bone loss induced by non-metastatic ovarian cancer in mice. J Bone Miner Res [Internet]. John Wiley & Sons, Ltd; 2022;37:381\u201396. Available from: 10.1002\/jbmr.4480. This study identifies tumor-derived circulating RANKL as an important factor contributing to bone loss and skeletal muscle atrophy in cachetic patients and ovarian cancer-bearing mice. Furthermore, anti-RANKL therapy was shown to be effective in improving both muscle and bone deficits."},{"key":"741_CR213","doi-asserted-by":"crossref","unstructured":"Essex AL, Pin F, Huot JR, Bonewald LF, Plotkin LI, Bonetto A. Bisphosphonate treatment ameliorates chemotherapy-induced bone and muscle abnormalities in young mice. Front Endocrinol (Lausanne) [Internet]. Frontiers Media S.A.; 2019;10:809. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31803146","DOI":"10.3389\/fendo.2019.00809"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-022-00741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-022-00741-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-022-00741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T10:33:52Z","timestamp":1664447632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-022-00741-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":213,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s11914-022-00741-y","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"25 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}